临床参数 |
| ALK (n = 104) | Non-ALK (n = 172) | Χ2 | p |
年龄(岁) | ≥60 | 38 (36.5%) | 104 (60.5%) | 14.854 | <0.001 |
<60 | 66 (63.5%) | 68 (39.5%) |
|
| |
性别 | 男 | 40 (38.5%) | 76 (44.2%) | 0.872 | 0.350 |
女 | 64 (61.5%) | 96 (55.8%) |
|
| |
吸烟史 | 无 | 83 (79.8%) | 113 (65.7%) | 6.269 | 0.012 |
有 | 21 (20.2%) | 59 (34.3%) |
|
| |
病理类型 | 腺癌 | 104 (100.0%) | 159 (92.4%) |
| 0.002a |
其他 | 0 (0.0%) | 13 (7.6%) |
|
| |
标本类型 | 手术标本 | 60 (57.7%) | 117 (68.0%) | 12.223 | 0.016 |
活检小标本 | 16 (15.4%) | 35 (20.3%) |
|
| |
纤支镜活检 | 11 (10.6%) | 8 (4.7%) |
|
| |
淋巴结活检 | 6 (5.7%) | 7 (4.1%) |
|
| |
其他 | 11 (10.6%) | 5 (2.9%) |
|
| |
原发部位 | 中央型 | 16 (15.4%) | 25 (14.5%) | 0.037 | 0.847 |
周围型 | 88 (84.6%) | 147 (85.5%) |
|
| |
转移情况 | 无 | 30 (28.8%) | 71 (41.3%) | 4.318 | 0.038 |
有 | 74 (71.2%) | 101 (58.7%) |
|
| |
TNM分期 | I、II | 41 (39.4%) | 93 (54.1%) | 5.566 | 0.018 |
III、IV | 63 (60.6%) | 79 (45.9%) |
|
|